Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2001, p. 266-272, Vol. 8, No. 2
Laboratory of Bacterial Polysaccharides,
Center for Biologics Evaluation and Research, Bethesda, Maryland
Received 24 July 2000/Returned for modification 9 October
2000/Accepted 21 November 2000
The specificity of the immune response to the 23-valent
pneumococcal-polysaccharide (PS) vaccine in healthy adults and to a
pneumococcal conjugate vaccine in infants was examined by measuring immunoglobulin G (IgG) antibody titers by enzyme-linked immunosorbent assay (ELISA) and the opsonophagocytosis assay. ELISA measures total
antipneumococcal IgG titers including the titers of functional and
nonfunctional antibodies, while the opsonophagocytosis assay measures
only functional-antibody titers. Twenty-four pairs of pre- and
post-pneumococcal vaccination sera from adults were evaluated (ELISA)
for levels of IgG antibodies against serotypes 4, 6B, 9V, 14, 18C, 19F,
and 23F. Twelve of the pairs were also examined (opsonophagocytosis
assay) for their functional activities. The correlation coefficients
between assay results for most types ranged from 0.75 to 0.90, but the
correlation coefficient was only about 0.6 for serotypes 4 and 19F. The
specificities of these antibodies were further examined by the use of
competitive ELISA inhibition. A number of heterologous polysaccharides
(types 11A, 12F, 15B, 22F, and 33A) were used as inhibitors. Most of
the sera tested showed cross-reacting antibodies, in addition to those removed by pneumococcal C PS absorption. Our data suggest the presence
of a common epitope that is found on most pneumococcal PS but that is
not absorbed by purified C PS. Use of a heterologous pneumococcal PS
(22F) to adsorb the antibodies to the common epitope increased the
correlation between the IgG ELISA results and the opsonophagocytosis
assay results. The correlation coefficient improve from 0.66 to 0.92 for type 4 and from 0.63 to 0.80 for type 19F. These
common-epitope antibodies were largely absent in infants at 7 months of
age, suggesting the carbohydrate nature of the epitope.
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.266-272.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Pneumococcal Type 22F Polysaccharide Absorption
Improves the Specificity of a Pneumococcal-Polysaccharide
Enzyme-Linked Immunosorbent Assay
*
Corresponding author. Mailing address: Division of
Bacterial Products, CBER, 1401 Rockville Pike, HFM-428, Rockville, MD
20852. Phone: (301) 496-1920. Fax: (301) 402-2776. E-mail:
frasch{at}cber.fda.gov.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |